Status:
UNKNOWN
Use of Fentanyl Patch in Partial Doses Than the Original
Lead Sponsor:
Meir Medical Center
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fentanyl is considered a potent synthetic opioid widely used in anesthesiology, for short and long-term pain management, and for sedation. The fentanyl patch is constructed like a matrix, a system bas...
Eligibility Criteria
Inclusion
- patients suffering from chronic pain on a fixed dose of fentanyl patch for over two weeks, with a maximum dose of 100 µg/h every two or three days, and have given their informed consent will be included in the study.
Exclusion
- Patients with cognitive problems
- non-Hebrew speaking
- patients that their medical condition prevents them from participation in the study.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT01403363
Start Date
March 1 2012
End Date
December 1 2016
Last Update
June 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pain clinic of Clalit Health Services-South District (CHS-SD)
Beersheba, Israel, 84418